Opinion|Videos|January 30, 2025
Improving the RCC Patient Journey and Future Therapeutic Directions
Panelists discuss areas for improvement in the RCC journey from the patient perspective, including the impact of emerging research on their experience, and explore therapeutic approaches and clinical research areas that show promise for improving outcomes in advanced RCC, with a focus on novel targets and mechanisms of action in development.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Based on your experience, what is your perspective on areas for improvement in the patient’s RCC journey? What is your perspective on the changing landscape and emerging research, and how has this impacted your experience as a patient?
- As we look ahead, what therapeutic approaches or clinical research areas are you most excited about for potentially improving outcomes in advanced RCC?
- Are there any novel targets or mechanisms of action in development that you are particularly excited about?
Advertisement
Related to this article
Matthew Matasar, MD, reflected on how quickly oncology has moved from skepticism to nimble adoption of AI, and what he expects from the field going forward.
Advertisement
Advertisement
Trending on CancerNetwork
1
IASO208 Receives FDA IND Clearance for Relapsed/Refractory B-Cell Lymphoma
2
WCLC 2026: How Will The Small Cell Lung Cancer Paradigm Change?
3
SOHO 2026: Key Updates Across the Multiple Myeloma Continuum
4
Secondary T-Cell Malignancies: Identifying and Counseling After CAR T-Cell Therapy
5